Advances in Gold Nanoparticles: Synthesis, Functionalization Strategies, and Theranostic Applications in Cancer.

Cancer is among the leading causes of mortality and morbidity in the world. Metallic nanoparticles, especially gold nanoparticles (AuNPs) have emerged to be attractive systems to circumvent the associated adverse effects. By the virtue of their unique properties of tunable size, shape, composition, optical properties, biocompatibility, minimal toxicity, multivalency, fluorescence-luminescence property and surface plasmon resonance; AuNPs have the potential to be used as drug delivery systems. It is vital to ensure that the drug reaches the target site of action for selective kill of cancer cells without harm to healthy cells. These AuNPs can be easily functionalized with a wide array of ligands like peptides, oligonucleotides, polymers, carbohydrates for active targeting to ensure site specific delivery and reduced systemic effects. AuNPs have been in-vestigated as carriers for gene delivery, drug delivery with or without photothermal therapy, in diagnosis based on radiation or spectroscopy. They have emerged as attractive theranostic approach in the overall management of cancer with superior benefit to risk features. In this review, we have discussed synthesis of different AuNPs (nanorods, spherical nanoparticles, and hollow AuNPs), their functionalization strategies and their applications in biomedical domain. Various research studies and clinical trials on application of AuNPs in diagnosis and therapeutics are highlighted.

Deoxyglucose-conjugated persistent luminescent nanoparticles for theragnostic application in fibrosarcoma tumor model.

Deoxyglucose conjugated nanoparticles with persistent luminescence have shown theragnostic potential. In this study, deoxyglucose-conjugated nano-particles with persistent luminescence properties were synthesized, and their theragnostic potential was evaluated in fibrosarcoma cancer cells and a tumor model. The uptake of nano-formulation was found to be higher in mouse fibrosarcoma (WEHI-164) cells cultured in a medium without glucose. Nanoparticles showed a higher killing ability for cancer cells compared to normal cells. A significant accumulation of nanoparticles to the tumor site in mice was evident by the increased tumor/normal leg ratio, resulting in a significant decrease in tumor volume and weight. Histopathological studies showed a significant decrease in the number of dividing mitotic cells but a greater number of apoptotic/necrotic cells in nanoparticle-treated tumor tissues, which was correlated with a lower magnitude of Ki-67 expression (a proliferation marker). Consequently, our results showed the potential of our nano-formulation for cancer theragnosis.

Development of Core@Shell γ-Fe2O3@MnxOy@SiO2 Nanoparticles for Hyperthermia, Targeting, and Imaging Applications.

Monodispersed core@shell γ-Fe2O3@MnxOy nanoparticles have been prepared through thermolysis of iron and manganese oleate. Further, these prepared nanoparticles are coated with biocompatible substances such as silica and polyethylene glycol. These particles are highly biocompatible for different cell lines such as normal and cancer cell lines. The nanoparticles are used as hyperthermia agents, and successful hyperthermia treatment in cancer cells is carried out. As compared to γ-Fe2O3@SiO2, γ-Fe2O3@MnxOy@SiO2 shows the enhanced killing of cancer cells through hyperthermia. In order to make them potential candidates for targeting to cancer cells, folic acid (FA) is tagged to the nanoparticles. Fluorescein isothiocyanate (FITC) is also tagged onto these nanoparticles for imaging. The developed γ-Fe2O3@MnxOy@SiO2 nanoparticle can act as a single entity for therapy through AC magnetic field, imaging through FITC and targeting through folic acid simultaneously. This is the first report on this material, which is highly biocompatible for hyperthermia, imaging, and targeting.

Synthesis of Hollow Gold Nanoparticles - Impact of Variables on Process Optimization.

Hollow gold nanoparticles (HAuNPs) are gold nanostructures with hollow interior. These particles have attracted a lot of interest due their excellent physicochemical and optical properties and their potential applications in diagnostics, sensing, imaging and assisting in tumor tracing and evaluating the effect of chemotherapy on tumor size, drug delivery and photothermal therapy. Sacrificial galvanic replacement using cobalt core is the most commonly used method for synthesis of HAuNPs. However, lack of reproducibility in synthesizing particles with desired surface plasmon resonance (SPR) is one of the major concerns for clinical application of these particles. In this work, we have identified and categorized various factors that could affect uniformity of cobalt core and subsequent formation of gold shell. Using slight modifications in the method, we have been able to synthesize HAuNPs with SPR in near infrared region at 808 nm with size of particles around 50-80 nm. HAuNPs can be further functionalized with suitable ligands like glutathione, polyethylene glycol, nucleic acids, sugars, fatty acids, proteins and peptides to promote enhanced permeability and retention in cancer cells and thus can serve as potential candidates in treatment of cancer.

Observation of Stark splitting in micro upconversion photoluminescence spectra of polycrystalline Ln3+ doped Y2O3microspheres.

In this study, Yb3+-Er3+-Tm3+doped Y2O3microspheres were synthesized using the solvothermal method. Structural, morphological, and elemental analysis was done using XRD, FESEM, and EDX characterization techniques. The optical properties of the samples were determined using UV-Vis-NIR spectroscopy and upconversion photoluminescence measurements. The anti-Stokes emission peaks from these polycrystalline phosphor microspheres were obtained using a commercial micro-photoluminescence setup equipped with a 976 nm laser as an excitation source at room temperature. It was compared with the emission spectra taken from a 2-3 mm spot size of 976 nm laser irradiation on the same sample. The micro-emission spectra were analyzed based on possible Stark splitting energy level transitions between the2S+1LJmanifolds of Er3+and Tm3+ions. A detailed mechanism is outlined for emission in the entire visible region under 976 nm laser excitation.

Brilliant Nonlinear Optical Response of Ho3+ and Yb3+ Activated YVO4 Nanophosphor and Its Conjugation with Fe3O4 for Smart Anticounterfeit and Hyperthermia Applications.

YVO4:Ho3+/Yb3+ nanophosphors prepared by an effective polyol-mediated route show dual-mode behavior in photoluminescence. Upon 980 nm excitation, the upconversion red emission spectrum exhibits a bright red peak at ∼650 nm, characteristic of the electronic transition of the Ho3+ ion via involvement of two-photon absorption, which has been confirmed by the power-dependent luminescence study. Moreover, at 300 nm excitation, downconversion emission peaks are observed at 550, 650, and ∼755 nm. The nonradiative resonant energy transfer occurs from the V-O charge transfer band to Ho3+ ions, resulting in an improved emission of Ho3+ ions. Moreover, polyethylene glycol-coated nanoparticles make it suitable for water dispersibility; and these particles are conjugated with Fe3O4 nanoparticles to form magnetic-luminescent hybrid nanoparticles. Highly water-dispersible magnetic-luminescent hybrid material attained the hyperthermia temperature (∼42 °C) under an applied AC magnetic field. The specific absorption rate value is found to be high (138 W/g), which is more than that of pure superparamagnetic Fe3O4 nanoparticles. At 300 nm excitation, the high quantum yield value of ∼27% is obtained from YVO4:Ho3+/Yb3+, which suggests that it is a good phosphor material. By employing the neutron activation analysis technique, it is shown that nanophosphor particles can absorb Au3+ up to the ppm level. Interestingly, such nanophosphor also shows the potentiality for anticounterfeiting applications.

Enrichment of Crystal Field Modification via Incorporation of Alkali K+ Ions in YVO4:Ho3+/Yb3+ Nanophosphor and Its Hybrid with Superparamagnetic Iron Oxide Nanoparticles for Optical, Advanced Anticounterfeiting, Uranyl Detection, and Hyperthermia Applications.

In this work, we report a polyol route for easy synthesis of upconversion (UC) phosphor nanoparticles, YVO4:Ho3+-Yb3+-K+, which enables large-scale production and enhancement of luminescence. Upon 980 nm laser excitation, the UC emission spectrum shows a sharp bright peak at ∼650 nm of Ho3+ ion; and the luminescence intensity increases twofold upon K+ codoping. Upon 300 nm excitation, the downconversion emission spectrum shows a broad peak in the 400-500 nm range (related to the charge transfer band of V-O) along with Ho3+ peaks. In addition, the polyethylene glycol-coated UC nanoparticles are highly water-dispersible and their hybrid with Fe3O4 nanoparticles shows magnetic-luminescence properties. A hyperthermia temperature is achieved from this hybrid. Both UC and hybrid nanoparticles show interesting security ink properties upon excitation by a 980 nm laser. The particles are invisible in normal light but visible upon 980 nm excitation and are useful in display devices, advanced anticounterfeiting purposes, and therapy of cancer via hyperthermia and bioimaging (since it shows red emission at ∼650 nm). Using UC nanoparticles, detection of uranyl down to 20 ppm has been achieved.

A Nitronaphthalimide Probe for Fluorescence Imaging of Hypoxia in Cancer Cells.

The bioreductive enzymes typically upregulated in hypoxic tumor cells can be targeted for developing diagnostic and drug delivery applications. In this study, a new fluorescent probe 4-(6-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)benzaldehyde (NIB) based on a nitronaphthalimide skeleton that could respond to nitroreductase (NTR) overexpressed in hypoxic tumors is designed and its application in imaging tumor hypoxia is demonstrated. The docking studies revealed favourable interactions of NIB with the binding pocket of NTR-Escherichia coli. NIB, which is synthesized through a simple and single step imidation of 4-nitro-1,8-naphthalic anhydride displayed excellent reducible capacity under hypoxic conditions as evidenced from cyclic voltammetry investigations. The fluorescence measurements confirmed the formation of identical products (NIB-red) during chemical as well as NTR-aided enzymatic reduction in the presence of NADH. The potential fluorescence imaging of hypoxia based on NTR-mediated reduction of NIB is confirmed using in-vitro cell culture experiments using human breast cancer (MCF-7) cells, which displayed a significant change in the fluorescence colour and intensity at low NIB concentration within a short incubation period in hypoxic conditions.

Metallic nanoparticles as drug delivery system for the treatment of cancer.

INTRODUCTION: The targeted delivery of anticancer agents to tumor is a major challenge because most of the drugs show off-target effect resulting in nonspecific cell death. Multifunctionalized metallic nanoparticles (NPs) are explored as new carrier system in the era of cancer therapeutics. Researchers investigated the potential of metallic NPs to target tumor cells by active and passive mechanisms, thereby reducing off-target effects of anticancer agents. Moreover, photocatalytic activity of upconversion nanoparticles (UCNPs) and the enhanced permeation and retention (EPR) effect have also gained wide potential in cancer treatment. Recent advancement in the field of nanotechnology highlights their potency for cancer therapy. AREAS COVERED: This review summarizes the types of gold and silver metallic NPs with targeting mechanisms and their potentiality in cancer therapy. EXPERT OPINION: Recent advances in the field of nanotechnology for cancer therapy offer high specificity and targeting efficiency. Targeting tumor cells through mechanistic pathways using metallic NPs for the disruption/alteration of molecular profile and survival rate of the tumor cells has led to an effective approach for cancer therapeutics. This alteration in the survival rate of the tumor cells might decrease the proliferation thereby resulting in more efficient management in the treatment of cancer.

Super Bright Red Upconversion in NaErF4:0.5%Tm@NaYF4:20%Yb Nanoparticles for Anti-counterfeit and Bioimaging Applications.

Nanocrystals having single-band red emission under near-infrared (NIR) excitation through the upconversion process offer great advantages in terms of enhanced cellular imaging in in vitro and in vivo experiments in the biological window (600-900 nm), as a security ink, in photothermal therapy (PTT), in photodynamic therapy (PDT), and so forth but are challenging for materials scientists. In this work, we report for the first time the preparation of a super bright red emitter at 655 nm from monodispersed NaErF4:0.5%Tm@NaYF4:20%Yb nanocrystals (core@active shell). This phosphor exhibits 35 times stronger photoluminescence as compared to NaErF4:0.5%Tm@NaYF4 (core@inactive shell). Here, an Er3+-enriched host matrix works simultaneously as an activator and a sensitizer under NIR excitation. Upconversion red emission at 655 nm arises due to the electronic transition of Er3+ via the involvement of a three-photon absorption (expected to be a two-photon absorption), which has been confirmed via a power-dependent luminescence study. Tm3+ ions incorporated into the core with the active shell act as trapping centers, which promote the red band emission via the back-energy transfer process. Moreover, the active shell containing Yb3+ ions efficiently transfers the energy to the Er3+-enriched core, which suppresses the nonradiative channel rate, and Tm3+ ions act as trapping centers, which reduce the luminescence quenching via reduction of energy migration to the surface of the host lattice. Also, we have shown the potential applications of these nanocrystals: cellular imaging through downconversion and upconversion processes and security ink.

Induction Heating Efficiency of Water-Dispersible Mn0.5Fe2.5O4@YVO4:Eu3+ Magnetic-Luminescent Nanocomposites in an Acceptable ac Magnetic Field: Hemocompatibility and Cytotoxicity Studies.

Not many reports are available on magnetic-luminescent nanocomposites for cancer hyperthermia applications. Further, such nanocomposites on Mn2+-doped iron oxide may be available rather rarely. Studies on the induction heating properties within the threshold magnetic field and frequency factors are still rare. In most cases, magnetic nanoparticles are studied for hyperthermia and lanthanide-doped luminescent nanoparticles for certain biomedical applications. Here, we report on water-dispersible superparamagnetic manganese-doped iron oxide (Mn0.5Fe2.5O4) nanoparticles and a polyethylene glycol6000-coated magnetic-luminescent nanocomposite. The nanocomposite is composed of magnetic Mn0.5Fe2.5O4 (average size 10-20 nm) nanoparticles and red-emitting YVO4:Eu3+ (average size 40-50 nm) nanoparticles. These magnetic nanoparticles and nanocomposites are studied for their induction heating abilities at different acceptable Hf values ( H, strength of alternating magnetic field and f, the operating frequency). The operational Hf values lie in the ranges of 2.15 × 106 to 4.58 × 106 kA m-1 s-1 that are well below the threshold limit of 5 × 106 kA m-1 s-1. A specific absorption rate as high as 132 and 63 W/g, respectively, for Mn0.5Fe2.5O4 and Mn0.5Fe2.5O4@YVO4:Eu3+, can be achieved. The rate of heating and the temperature achieved with time can be tuned with concentrations as well as magnetic constituents in the nanocomposites. Hemocompatibility analysis revealed high blood compatibility with <5% hemolysis. The cytotoxicity analysis in the MCF-7 cell line showed that the cell viability is 74-85% for 0.2-0.5 mg of the magnetic-luminescent nanocomposites. Beyond this concentration, the percentage of cell death is very high. The red-emitting magnetic-luminescent nanocomposites will be useful for in vitro optical imaging and tracking of magnetic nanoparticles. The magnetization analysis showed that the samples have high enough saturation magnetization and low residual magnetization, which is quite suitable for clinical applications. The water dispersibility, hemocompatibility, and cytotoxicity assay in conjunction with their efficient induction heating abilities have shown that these magnetic-luminescent nanocomposites will have potential applications in magnetic fluid hyperthermia and optical imaging.

Magnetic nanoparticle-mediated hyperthermia therapy induces tumour growth inhibition by apoptosis and Hsp90/AKT modulation.

PURPOSE: We have evaluated the hyperthermia efficacy of oleic acid-functionalised Fe(3)O(4) magnetic nanoparticles (MN-OA) under in vivo conditions and elucidated the underlying mechanism of tumour growth inhibition. MATERIALS AND METHODS: The efficacy and mechanism of tumour growth inhibition by MN-OA-mediated magnetic hyperthermia therapy (MHT) was evaluated in a murine fibrosarcoma tumour model (WEHI-164) using techniques such as TUNEL assay, Western blotting (WB), immunofluorescence (IF) staining and histopathological examination. In addition, bio-distribution of MN-OA in tumour/other target organs and its effect on normal organ function were studied by Prussian blue staining and serum biochemical analysis, respectively. RESULTS: MN-OA-induced MHT resulted in significant inhibition of tumour growth as determined by measurement of tumour volume, as well as by in vivo imaging of tumour derived from luciferase-transfected WEHI-164 cells. Histopathology analysis showed presence of severe apoptosis and reduced tumour cells proliferation, which was further confirmed by TUNEL assay, reduced expression of Ki-67 and enhanced level of cleaved caspase-3, in tumours treated with MHT. Moreover, expression of heat stress marker, Hsp90 and its client protein, AKT/PKB was reduced by ∼50 and 80%, respectively, in tumours treated with MHT as studied by WB and IF staining. Serum analysis suggested insignificant toxicity of MN-OA (in terms of liver and kidney function), which was further correlated with minimal accumulation of MN-OA in target organs. CONCLUSIONS: These results suggest the involvement of apoptosis and Hsp90/AKT modulation in MN-OA-mediated MHT-induced tumour growth inhibition.

Radiolanthanide-loaded agglomerated Fe3O4 nanoparticles for possible use in the treatment of arthritis: formulation, characterization and evaluation in rats.

This investigation reports the preparation of agglomerated Fe3O4 nanoparticles and evaluation of its utility as a viable carrier in the preparation of radiolanthanides as potential therapeutic agents for the treatment of arthritis. The material was synthesized by a chemical route and characterized by XRD, FT-IR, SEM, EDX and TEM analysis. The surface of agglomerated particle possessed ion pairs (-O-:Na+) after dispersing particles in a NaHCO3 solution at pH = 7 which is conducive for radiolanthanide (*Ln = 90Y, 153Sm, 166Ho, 169Er, 177Lu) loading by replacement of Na+ ions with tripositive radiolanthanide ions. Radiolanthanide-loaded particulates exhibited excellent in vitro stability up to ∼3 half-lives of the respective lanthanide radionuclides when stored in normal saline at 37 °C. The radiochemical purities of the loaded particulates were found to be retained to the extent of >70% after 48 h of storage when challenged by a strong chelator DTPA present at a concentration as high as 5 mM, indicating fairly strong chemical association of lanthanides with agglomerated Fe3O4 nanoparticles. Biodistribution studies of 90Y and 166Ho-loaded particulates carried out after intra-articular injection into one of the knee joints of a normal Wistar rat revealed near-complete retention of the radioactive preparations (>98% of the administered radioactivity) within the joint cavity even after 72 h post injection. This was further confirmed by sequential whole-body radio-luminescence imaging. These experimental results are indicative of the potential use of radiolanthanide-loaded agglomerated Fe3O4 nanoparticles for the treatment of arthritis.

Enhanced specific absorption rate in silanol functionalized Fe3O4 core-shell nanoparticles: study of Fe leaching in Fe3O4 and hyperthermia in L929 and HeLa cells.

Core-shell Fe3O4-SiO2 magnetic nanoparticles (MNPs) have been synthesized using a simple synthesis procedure at different temperatures. These MNPs are used to investigate the effect of surface coating on specific absorption rate (SAR) under alternating magnetic field. The temperature achieved by silica coated Fe3O4 is higher than that by uncoated MNPs (Fe3O4). This can be attributed to extent of increase in Brownian motion for silica coated MNPs. The sample prepared at optimized temperature of 80°C shows the highest SAR value of 111W/g. It is found that SAR value decreases with increase in shell thickness. The chemical stability of these samples is analyzed by leaching experiments at pH 2-7. The silica coated samples are stable up to 7 days even at pH 2. Biocompatibility of the MNPs is evaluated in vitro by assessing their cytotoxicity on L929 and human cervical cancer cells (HeLa cells) using sulforhodamine-B assay. Their hyperthermic killing ability is also evaluated in HeLa cells using the same method. Cells treated with MNPs along with induction heating show decrease in viability as compared to that without induction heating. Further, cell death is found to be ∼55% more in cells treated with silica coated MNPs under induction heating as compared to untreated control. These results establish the efficacy of Fe3O4-SiO2 prepared at 80°C in killing of tumor cells by cellular hyperthermia.

Is higher ratio of monoclinic to tetragonal in LaVO4 a better luminescence host? Redispersion and polymer film formation.

Crystalline LaVO4:Eu(3+) nanophosphors (NPs) codoped with metal ions (M(n+) = Li(+), Sr(2+), and Bi(3+)) are prepared in ethylene glycol (EG) medium at temperature ∼140 °C in 3 h. A mixture of monoclinic and tetragonal phases is observed. The ratio of tetragonal to monoclinic phases increases with increase of Li(+) and Sr(2+) concentration, but this is opposite in case of Bi(3+) concentration. Lattice expansion occurs in the case of Li(+) and Sr(2+) codoping. Li(+) ions occupy the interstitial sites instead of La(3+) sites. Lattice contraction occurs in case of Bi(3+) codoping indicating substitution of La(3+) sites. Luminescence intensity is improved by codoping of M(n+) irrespective of crystal structure. Charges of Li(+) and Sr(2+) are different from that of La(3+) (host lattice), whereas the charge of Bi(3+) is same as that of La(3+). One interesting observation is in magnetic dipole transition that the intensity of the peak at 594 nm is more than that at 587 nm in the case of charge imbalance, whereas the reverse occurs in the case of charge balance. LaVO4:Eu(3+) nanophosphors prepared in water medium have more luminescence intensity when compared to those prepared in ethylene glycol, and this is related to variation of ratio of tetragonal to monoclinic phases. The luminescence intensity is also enhanced as annealing temperature increases from 600 to 800 °C due to the improved crystallinity. Lifetime data are analyzed on the basis of exponential and nonexponential decay equations. Samples are dispersible in polar medium due to capping of particles by EG. Polymer films are prepared by dispersion of NPs in poly(vinyl alcohol), and extra borax is added in order to make cross-link between polymer molecules. Samples of NPs in the forms of powder, dispersion in liquid medium, and film show the red emission.

Preparation and structure refinement of Eu3+ doped CaMoO4 nanoparticles.

The nanoparticles of CaMoO(4) : Eu(3+) (Eu(3+) = 0, 1, 3, 5, 7, 10 at. %) are prepared at low temperature (150 °C for 3 h) using urea hydrolysis in ethylene glycol. These are characterized by X-ray diffraction (XRD), infrared spectroscopy (IR) and transmission electron microscopy (TEM). From XRD study, it was found that the solubility limit of Eu(3+) ions at the Ca(2+) sites is up to 3 at. % and above this, phase segregation occurs. In combination with Rietveld analysis, its crystal structure was found to be tetragonal phase (space group I4(1)/a (88) and Z = 4 (number of CaMoO(4) formula units per unit cell). Unit cell parameters and bond distances are calculated. The average crystallite sizes of as-prepared, 500 and 900 °C heated samples are found to be 20, 35 and 70 nm, respectively. The lattice strain is found to be 0.003-0.005. From IR study, the bands at 820 and 441 cm(-1) are assigned to asymmetric stretching and bending vibrations of the MoO(4)(2-) tetrahedron, respectively. From TEM study, the shape of particle was found to be spherical. The high resolution TEM suggests a change in orientation of the crystal on annealing up to 900 °C.

Luminescence properties of Eu3+ doped CaMoO4 nanoparticles.

When Eu(3+) ions occupy Ca(2+) sites of CaMoO(4), which has a body centered tetragonal structure with inversion symmetry, only the magnetic dipole transition ((5)D(0)→(7)F(1)) should be allowed according to Judd-Ofelt theory. Even if there are a few distortions in the Eu(3+) environment, its intensity should be more than that of the electric dipole transition ((5)D(0)→(7)F(2)). We report here the opposite effect experimentally and ascribe this to the polarizability effect of the MoO(4) tetrahedron, which is neighboring to EuO(8) (symmetric environment). The contribution of the energy transfer process from the Mo-O charge transfer band to Eu(3+) and the role of Eu(3+) over the surface of the particle could be distinguished when luminescence decay processes were measured at two different excitations (250 and 398 nm). Further, the luminescence intensities and lifetimes increase significantly with increasing heat-treatment temperature of the doped samples. This is attributed to the reduction of H(2)O from the surface of the particles and a non-radiative process after heat treatment.

Eu3+ and Dy3+ doped YPO4 nanoparticles: low temperature synthesis and luminescence studies.

Eu3+ and Dy3+ doped YPO4 nanoparticles dispersible in methanol/water were prepared by the reaction of Y3+ and Eu3+/Dy3+ ions with ammonium dihydrogen phosphate in ethylene glycol medium at 160 degrees C. Nature and extent of strain associated with lattice has been found to change with incorporation of Eu3+/Dy3+ ion in the nanoparticles as well as the heat treatment temperature. Based on the TEM studies, it has been established that particles are highly crystalline with an average particle size of around 5 nm. Co-doping YPO4:Eu nanoparticles with Dy3+ ions followed by annealing them at high temperature (900 degrees C) lead to reduction in both Eu3+ and Dy3+ luminescence intensities from the sample and this has been attributed to the clustering effect of the lanthanide ions.

Room temperature exciton formation in SnO2 nanocrystals in SiO2:Eu matrix: quantum dot system, heat-treatment effect.

SnO2 nanocrystals in SiO2:Eu matrix have been prepared at a relatively low temperature of 170 degrees C for 4 h. Selective transition probability of Eu3+ emission could be done after a suitable excitation wavelength. The room temperature exciton formation at 285 nm for as-prepared nanoparticles is observed and this gives the Bohr's radius of 1.4 nm. Exciton formation disappears for the nanoparticles heated at 500 and 900 degrees C. This is related to the increase in particle size with heat-treatment. A wide-band-gap (4.35 eV) quantum dots is obtained and will be important in photonics and UV-lasing application.